LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will be a panelist at the Small and Emerging Private Equity Manager Conference, organized by Credit Suisse's Customized Fund Investment Group, in Houston.
News | 04. 19. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.